A Roadmap For Immunotherapy Success In Oncology
6 comments | February 21, 2012 |
includes:
AMGN, BMY, CELG, DNDN, GALE, GSK, IMUC.OB, MRK, NVS, ONTY
.....According to Henry Gosebruch, managing director of health-care mergers and acquisitions at J.P. Morgan, analysts at the firm expect the following:
"The large biotechs (will look) to be active acquirers in 2012.
Investors have rewarded strategic acquisitions that enhance long-term growth and companies that continue their history of developing innovative therapies, as opposed to turning into dividend-paying, share-repurchase type low-growth stocks."
The above sentiment is further supported by a report from Bloomberg, which showcased how biotech companies have historically been less active than their pharmaceutical industry counterparts regarding M&A activity.
For example, over the past 4 years, Bristol-Myers Squibb (BMY) has completed an impressive 17 acquisitions, while biotech industry heavyweight, Celgene (CELG), has completed a mere 3 acquisitions.....
http://seekingalpha.com/article/379931-a-roadmap-for-immunotherapy-success-in-oncology?source=yahoo
- Forums
- ASX - By Stock
- immunotherapy based biotechs into 2012
A Roadmap For Immunotherapy Success In Oncology6 comments |...
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMM (ASX) to my watchlist
(20min delay)
|
|||||
Last
29.5¢ |
Change
-0.040(11.9%) |
Mkt cap ! $428.5M |
Open | High | Low | Value | Volume |
32.0¢ | 33.0¢ | 28.0¢ | $7.278M | 23.75M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 53192 | 29.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
30.5¢ | 41048 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 51196 | 0.295 |
9 | 230902 | 0.290 |
5 | 74631 | 0.285 |
22 | 480847 | 0.280 |
4 | 114783 | 0.275 |
Price($) | Vol. | No. |
---|---|---|
0.305 | 41048 | 1 |
0.310 | 25000 | 2 |
0.315 | 10525 | 1 |
0.320 | 76654 | 4 |
0.325 | 30000 | 1 |
Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online